|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,300.00 GBX | +0.19% |
|
+1.92% | +7.16% |
| 01-27 | British Equities Rally Amid Leasehold System Overhaul; HSBC Shares Hit Record High | MT |
| 01-27 | Siegfried Raises the Stakes, Crédit Agricole Builds Momentum... Dr. Martens Stumbles |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.9B | 2.01B | 2.32B | 2.6B | 2.72B | |||||
Total Revenues | 1.9B | 2.01B | 2.32B | 2.6B | 2.72B | |||||
Cost of Goods Sold, Total | 1.63B | 1.73B | 2.02B | 2.22B | 2.3B | |||||
Gross Profit | 269M | 281M | 301M | 375M | 420M | |||||
Selling General & Admin Expenses, Total | 136M | 140M | 164M | 195M | 212M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 3.5M | 4.2M | 5.2M | 5M | 3.6M | |||||
Other Operating Expenses, Total | 140M | 144M | 169M | 200M | 216M | |||||
Operating Income | 129M | 137M | 132M | 175M | 204M | |||||
Interest Expense, Total | -3M | -3.8M | -6.5M | -8.9M | -9.2M | |||||
Interest And Investment Income | - | - | - | - | - | |||||
Net Interest Expenses | -3M | -3.8M | -6.5M | -8.9M | -9.2M | |||||
Income (Loss) On Equity Invest. | - | - | - | 400K | 200K | |||||
Other Non Operating Income (Expenses) | - | - | - | - | - | |||||
EBT, Excl. Unusual Items | 126M | 133M | 125M | 166M | 195M | |||||
Merger & Related Restructuring Charges | - | -600K | -100K | -600K | -700K | |||||
Impairment of Goodwill | - | - | - | -15.1M | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Asset Writedown | -11.4M | -2.8M | 4.6M | 1.9M | -12.7M | |||||
Insurance Settlements | - | - | 9.9M | 5.7M | - | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | 115M | 130M | 140M | 158M | 182M | |||||
Income Tax Expense | 22.3M | 26.4M | 28.1M | 45.3M | 47.3M | |||||
Earnings From Continuing Operations | 92.5M | 104M | 111M | 113M | 134M | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 92.5M | 104M | 111M | 113M | 134M | |||||
Net Income - (IS) | 92.5M | 104M | 111M | 113M | 134M | |||||
Net Income to Common Incl Extra Items | 92.5M | 104M | 111M | 113M | 134M | |||||
Net Income to Common Excl. Extra Items | 92.5M | 104M | 111M | 113M | 134M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 1.76 | 1.96 | 2.08 | 2.1 | 2.51 | |||||
Basic EPS - Continuing Operations | 1.76 | 1.96 | 2.08 | 2.1 | 2.51 | |||||
Basic Weighted Average Shares Outstanding | 52.47M | 52.92M | 53.46M | 53.78M | 53.58M | |||||
Net EPS - Diluted | 1.76 | 1.95 | 2.08 | 2.1 | 2.46 | |||||
Diluted EPS - Continuing Operations | 1.76 | 1.95 | 2.08 | 2.1 | 2.46 | |||||
Diluted Weighted Average Shares Outstanding | 52.71M | 53.17M | 53.59M | 53.96M | 54.54M | |||||
Normalized Basic EPS | 1.5 | 1.57 | 1.46 | 1.94 | 2.27 | |||||
Normalized Diluted EPS | 1.5 | 1.57 | 1.46 | 1.93 | 2.23 | |||||
Dividend Per Share | 0.7 | 0.76 | 0.79 | 0.9 | 1.01 | |||||
Payout Ratio | 30.16 | 31.69 | 32.59 | 38.82 | 36.86 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 185M | 189M | 191M | 246M | 276M | |||||
EBITA | 133M | 141M | 137M | 180M | 208M | |||||
EBIT | 129M | 137M | 132M | 175M | 204M | |||||
EBITDAR | 186M | 190M | 192M | 247M | 277M | |||||
Effective Tax Rate - (Ratio) | 19.42 | 20.32 | 20.14 | 28.6 | 26.05 | |||||
Current Domestic Taxes | 26.1M | 13.2M | 25.8M | 38.5M | 42.3M | |||||
Total Current Taxes | 26.1M | 13.2M | 25.8M | 38.5M | 42.3M | |||||
Deferred Domestic Taxes | - | - | - | - | - | |||||
Total Deferred Taxes | -3.8M | 13.2M | 2.3M | 6.8M | 5M | |||||
Normalized Net Income | 78.88M | 83.31M | 78.19M | 104M | 122M | |||||
Interest Capitalized | - | - | - | 300K | - | |||||
Interest on Long-Term Debt | 3M | 3.8M | 6.5M | 8.9M | 9.2M | |||||
Non-Cash Pension Expense | -200K | -100K | -100K | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 69M | 80.3M | 94.8M | 100M | 113M | |||||
General and Administrative Expenses | 67.7M | 59.5M | 69.4M | 94.7M | 99.5M | |||||
Research And Development Expense From Footnotes | 6.9M | 9.1M | 10.8M | 29M | 24M | |||||
Net Rental Expense, Total | 1M | 1M | 1.2M | 1.9M | 1.7M | |||||
Imputed Operating Lease Interest Expense | 160K | 256K | 548K | 1.13M | 821K | |||||
Imputed Operating Lease Depreciation | 840K | 744K | 652K | 773K | 879K | |||||
Stock-Based Comp., Other (Total) | 6M | 6.9M | 4.7M | 8.8M | 8.4M | |||||
Total Stock-Based Compensation | 6M | 6.9M | 4.7M | 8.8M | 8.4M |
- Stock Market
- Equities
- CWK Stock
- Financials Cranswick plc
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















